Balanced news tone
News Sentiment
AVLN sentiment intelligence
Avalyn Pharma Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
80/100 classification confidence.
directly relevant articles
high-authority source matches
+0.9% over one week, -10.0% over four weeks, trend inactive, and near fair-value range.
Price to sales forward of Avalyn Pharma Inc. – NASDAQ:AVLN
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Avalyn Pharma (AVLN) Stock Trends and Sentiment 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 May 2026 02:41
- Source
- MarketBeat
Avalyn Pharma (AVLN) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 May 2026 02:41
- Source
- MarketBeat
Avalyn Pharma Inc. (AVLN) Stock Price | Live Quotes & Charts | NASDAQ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 08:01
- Source
- StocksToTrade
Avalyn Pharma closes $345 million IPO on Nasdaq
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Investing.com
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Market source
Pulmonary drug developer Avalyn surges on IPO (AVLN:NASDAQ)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Seeking Alpha
Is Avalyn Pharma (NASDAQ:AVLN) In A Good Position To Invest In Growth?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Market source
Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials
- Tone
- Positive 66/100
- Event
- Balance sheet
- Published
- 30 Apr 2026 07:00
- Source
- MedCity News
Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Fierce Biotech
GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- StockStory
symbol__ Stock Quote Price and Forecast
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 25 Apr 2026 19:18
- Source
- CNN
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
AVLN Stock Price and Chart — NASDAQ:AVLN
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Apr 2026 09:28
- Source
- TradingView
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
AVALYN PHARMACEUTICALS (AVLN) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Mar 2026 21:51
- Source
- Stock Titan
Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- Market source
Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 Mar 2026 08:00
- Source
- Stocktwits
Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Feb 2026 09:53
- Source
- Kavout | AI
Cava Stock Surges 24% After Upbeat Earnings and Strong 2026 Outlook
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 26 Feb 2026 08:00
- Source
- TIKR.com
Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 25 Feb 2026 08:00
- Source
- TIKR.com
This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Barron's
Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Feb 2026 08:00
- Source
- Barron's
HROW Stock Price and Chart — NASDAQ:HROW
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jan 2019 19:43
- Source
- TradingView